James E Flynn Insider Trading $ISPH INSPIRE PHARMACEUTICALS INC
Get free email notifications about insider trading for James E Flynn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James E Flynn. James E Flynn is 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and 10% Owner in AxoGen, Inc. ($LECT) and 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in STREAMLINE HEALTH SOLUTIONS INC. ($LANV) and 10% Owner in ANTARES PHARMA, INC. ($ATRS) and 10% Owner in VIA Pharmaceuticals, Inc. ($CAQ) and 10% Owner in DUSA PHARMACEUTICALS INC ($DUSA) and 10% Owner in HI TECH PHARMACAL CO INC ($HITK) and 10% Owner in AVADEL PHARMACEUTICALS PLC ($AVDL) and 10% Owner in INSPIRE PHARMACEUTICALS INC ($ISPH) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARENA PHARMACEUTICALS INC ($ARNA) and 10% Owner in ISTA PHARMACEUTICALS INC ($ISTA) and 10% Owner in MEDICINES CO /DE ($MDCO) and 10% Owner in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Director in Talon Therapeutics, Inc. ($EMLR) and 10% Owner in LUMOS PHARMA, INC. ($NLNK) and 10% Owner in NITROMED INC ($NTMD) and 10% Owner in XENOPORT INC ($XNPT) and 10% Owner in EMAGEON INC ($EMAG) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in NeuroMetrix, Inc. ($NURO) and 10% Owner in NxStage Medical, Inc. ($NXTM) and 10% Owner in aTYR PHARMA INC ($LIFE) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and Director in PROTEON THERAPEUTICS INC ($PRTO) and 10% Owner in eHealth, Inc. ($EHTH) and 10% Owner in ZAFGEN, INC. ($ZFGN) and 10% Owner in NeurogesX Inc ($NGSX) and 10% Owner in Invuity, Inc. ($IVTY) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and 10% Owner in TriVascular Technologies, Inc. ($TRIV) and 10% Owner in Auspex Pharmaceuticals, Inc. ($ASPX) and 10% Owner in Neos Therapeutics, Inc. ($NEOS) and 10% Owner in Schrodinger, Inc. ($SDGR) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in Acutus Medical, Inc. ($AFIB) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Mallinckrodt plc ($MNK) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Adverum Biotechnologies, Inc. ($AAVL) and 10% Owner in REGENXBIO Inc. ($RGNX) and 10% Owner in Recro Pharma, Inc. ($REPH) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and Director in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in ShockWave Medical, Inc. ($SWAV) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Editas Medicine, Inc. ($EDIT) and Director in AveXis, Inc. ($AVXS) and 10% Owner in ARVINAS INC. ($ARVN) and 10% Owner in Homology Medicines, Inc. ($FIXX) and Director in Homology Medicines, Inc. ($FIXX) and Director in Oncorus, Inc. ($ONCR) and 10% Owner in Revolution Medicines, Inc. ($RVMD) and 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and 10% Owner in Frequency Therapeutics, Inc. ($FREQ) and Director in DFB Healthcare Acquisitions Corp. ($DFBH) and 10% Owner in Generation Bio Co. ($GBIO) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and Director in DFP HEALTHCARE ACQUISITIONS CORP. ($DFPH) and Director in Deerfield Healthcare Technology Acquisitions Corp. ($DFHT) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).
James E Flynn in INSPIRE PHARMACEUTICALS INC
Trading Symbol: ISPHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 2,307,449 shares
Latest Transaction: May 02 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of James E Flynn in INSPIRE PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACRS, AFIB, DFBH, ADVM, ALIM, ALPN, ANNX, ATRS, ARNA, ARVN, LIFE, BOLD, ASPX, AVDL, AVXS, LECT, BDTX, CABA, CAMY.OB, CBIO, CNST, CYCC, CTMX, DFHTW, DFPHU, DRNA, DUSA, DVAX, EWTX, EDIT, EHTH, EMAG, FCSC, FREQ, GBIO, HITK, FIXX, ISPH, IVTY, ISTA, KNSA, LRMR, LOXO, NLNK, MNK, MDCO, MIRM, NEOS, NGSX, NURO, NTMD, NKTX, NXTM, ONCR, PRX, TARA, REPH, RGNX, RVMD, RYTM, RIGL, SDGR, SWAV, STDY, LANV, SYRS, EMLR, TERN, TWTI, TRIV, VNDA, CAQ, HOWL, XNPT, XERS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 02 2007 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Sell | S | 7.73 | 177,129 | 1,369,792 | 2,307,449 | 2.5 M to 2.3 M (-7.13 %) |
May 02 2007 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Sell | S | 7.73 | 134,645 | 1,041,250 | 1,754,062 | 1.9 M to 1.8 M (-7.13 %) |
May 02 2007 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Sell | S | 7.73 | 59,879 | 463,068 | 781,151 | 841 K to 781.2 K (-7.12 %) |
May 02 2007 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Sell | S | 7.73 | 31,677 | 244,968 | 413,293 | 445 K to 413.3 K (-7.12 %) |
May 11 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.84 | 88,844 | 430,120 | 841,030 | 752.2 K to 841 K (+11.81 %) |
May 11 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.84 | 44,156 | 213,772 | 444,970 | 400.8 K to 445 K (+11.02 %) |
May 11 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.87 | 44,756 | 217,854 | 752,186 | 707.4 K to 752.2 K (+6.33 %) |
May 11 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.87 | 22,244 | 108,275 | 400,814 | 378.6 K to 400.8 K (+5.88 %) |
May 04 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.85 | 49,706 | 241,074 | 707,430 | 657.7 K to 707.4 K (+7.56 %) |
May 04 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.85 | 24,704 | 119,814 | 378,570 | 353.9 K to 378.6 K (+6.98 %) |
Apr 13 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.85 | 6,681 | 32,403 | 657,724 | 651 K to 657.7 K (+1.03 %) |
Apr 13 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.85 | 3,319 | 16,097 | 353,866 | 350.5 K to 353.9 K (+0.95 %) |
Apr 13 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.85 | 51,661 | 250,556 | 2,484,578 | 2.4 M to 2.5 M (+2.12 %) |
Apr 13 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.85 | 38,339 | 185,944 | 1,888,707 | 1.9 M to 1.9 M (+2.07 %) |
Mar 09 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.95 | 53,430 | 264,238 | 651,043 | 597.6 K to 651 K (+8.94 %) |
Mar 09 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.95 | 28,770 | 142,282 | 350,547 | 321.8 K to 350.5 K (+8.94 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.74 | 1,024 | 4,854 | 597,613 | 596.6 K to 597.6 K (+0.17 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.75 | 23,267 | 110,525 | 596,589 | 573.3 K to 596.6 K (+4.06 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.55 | 33,032 | 150,296 | 573,322 | 540.3 K to 573.3 K (+6.11 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.74 | 551 | 2,612 | 321,777 | 321.2 K to 321.8 K (+0.17 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.75 | 12,527 | 59,507 | 321,226 | 308.7 K to 321.2 K (+4.06 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.55 | 17,785 | 80,922 | 308,699 | 290.9 K to 308.7 K (+6.11 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.74 | 4,388 | 20,799 | 2,431,397 | 2.4 M to 2.4 M (+0.18 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.72 | 85,200 | 402,144 | 2,427,009 | 2.3 M to 2.4 M (+3.64 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.75 | 99,694 | 473,576 | 2,341,809 | 2.2 M to 2.3 M (+4.45 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.55 | 141,536 | 643,989 | 2,242,115 | 2.1 M to 2.2 M (+6.74 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.74 | 3,337 | 15,817 | 1,849,213 | 1.8 M to 1.8 M (+0.18 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.72 | 64,800 | 305,856 | 1,845,876 | 1.8 M to 1.8 M (+3.64 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.75 | 75,822 | 360,177 | 1,781,076 | 1.7 M to 1.8 M (+4.45 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.55 | 107,647 | 489,794 | 1,705,254 | 1.6 M to 1.7 M (+6.74 %) |
Mar 30 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.78 | 1,520 | 7,266 | 2,432,917 | 2.4 M to 2.4 M (+0.06 %) |
Mar 30 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.78 | 1,155 | 5,521 | 1,850,368 | 1.8 M to 1.9 M (+0.06 %) |
Page: 1